Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2025 08:00 ET | Source: Employ Inc.

Smarter Hiring – with Measurable Results: Employ Showcases AI-Driven Impact at HR Tech 2025

Smarter Hiring – with Measurable Results: Employ Showcases AI-Driven Impact at HR Tech 2025
September 16, 2025 08:00 ET | Source: PageUp

PageUp Drives the Future of Hiring with New AI Suite and ‘Paige’ the Recruiter Co-Pilot

PageUp Drives the Future of Hiring with New AI Suite and ‘Paige’ the Recruiter Co-Pilot
August 17, 2025 19:00 ET | Source: PageUp

PageUp Infuses AI Across its Hiring Platform to Automate Repetitive Tasks and Accelerate Smart Hiring

PageUp's Mid-Year Release Helps Overwhelmed Recruiting Teams Navigate Overwhelming Applicant Volumes to Hire More Efficiently
July 29, 2025 09:00 ET | Source: Employ Inc.

Smarter Hiring Starts Here: Employ’s New AI Release Prioritizes Recruiter Efficiency and Human Connection

Smarter Hiring Starts Here: Employ’s New AI Release Prioritizes Recruiter Efficiency and Human Connection
June 05, 2025 13:09 ET | Source: Foundation for Sarcoidosis Research

The Foundation for Sarcoidosis Research and American Thoracic Society Announce Dr. Mark Mallozzi as the New FSR/ATS Partner Grant Awardee

Mark Mallozzi, MD, MPH has been selected to receive the 2025 ATS/FSR Partner Grant.
May 20, 2025 08:00 ET | Source: Employ Inc.

Employ Appoints Suzanne Tran as Chief Marketing Officer to Drive Growth and Market Impact

Market-Leading Hiring Suite Employ Appoints Suzanne Tran as Chief Marketing Officer
May 20, 2025 07:00 ET | Source: HR Tech

Leading Change Together: HR Tech 2025 Reveals Initial Agenda

HR Tech 2025 Reveals Initial Agenda, Features Sessions on AI, Coaching, People Analytics, Recruiting, Skills Strategy and More
May 19, 2025 12:15 ET | Source: Kymera Therapeutics, Inc.

Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the American Thoracic Society International Conference

KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable or superior activity to dupilumab in a newly disclosed preclinical chronic asthma model reversing disease progression KT-621...
May 19, 2025 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Presents Three Posters on Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference

aTyr Pharma Presents Three Posters on Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference
May 14, 2025 09:00 ET | Source: Employ Inc.

Desk-Based Roles See Application Surges Amid Slowing Demand, Growing AI Adoption, While Frontline and Hourly Workforce Face Talent Shortages

New Employ data reveals a growing divide in labor demand, competition, and technology use between the two job markets